Galaxy Surfactants Limited

NSE:GALAXYSURF.NS

2444.4 (INR) • At close January 15, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q4
Revenue 10,629.99,740.69,2909,404.99,831.29,417.79,744.710,802.612,316.311,588.810,199.59,290.98,7738,263.87,448.16,7477,186.86,071.66,235.56,258.96,488.26,650.26,508.36,794.76,853.37,161.96,435.65,978.76,101.15,823.76,021.4
Cost of Revenue 7,126.17,504.87,241.16,415.46,738.16,3676,587.77,390.99,004.68,017.67,251.16,740.66,444.75,642.35,132.54,200.44,577.43,995.34,317.84,216.44,330.14,428.44,7834,7714,833.25,214.44,624.94,265.74,401.44,219.14,419.4
Gross Profit 3,503.82,235.82,048.92,989.53,093.13,050.73,1573,411.73,311.73,571.22,948.42,550.32,328.32,621.52,315.62,546.62,609.42,076.31,917.72,042.52,158.12,221.81,725.32,023.72,020.11,947.51,810.71,7131,699.71,604.61,602
Gross Profit Ratio 0.330.230.2210.3180.3150.3240.3240.3160.2690.3080.2890.2740.2650.3170.3110.3770.3630.3420.3080.3260.3330.3340.2650.2980.2950.2720.2810.2870.2790.2760.266
Reseach & Development Expenses 00308.7000275000293.4000269.2000269000261.1000260.70000
General & Administrative Expenses 0000000000000000000000000000000
Selling & Marketing Expenses 0000000000000000000000000000000
SG&A 0769.41,294.51,188.61,198.3713.21,1771,271.41,367.5618.6700.8515.8478995.11,100490.6497.9462.9590.8432427.5456.4533408417.6382.6493.5350.3366.9366.4295.6
Other Expenses 3,503.80239.163.826.824.970.337.410.8-20-14.617.650.445.2-37.330.445.76.7-19.133.61312.587.910.318.9-17.215.725.627.530.50
Operating Expenses 3,503.8769.41,294.52,115.92,090.82,056.92,0372,086.72,199.62,280.31,674.31,963.81,800.61,7051,309.31,520.41,561.21,3361,046.41,385.41,431.41,409.7901.61,328.41,279.21,185.71,235.11,080.61,082.11,036.4983.3
Operating Income 02,501.4754.4937.41,029.1993.81,190.31,362.41,122.91,290.91,265.8586.5527.7916.5942.81,056.61,048.2740.3871.3657.1726.7812.1823.7695.3740.9761.8575.6632.4617.6568.2558.9
Operating Income Ratio 00.2570.0810.10.1050.1060.1220.1260.0910.1110.1240.0630.060.1110.1270.1570.1460.1220.140.1050.1120.1220.1270.1020.1080.1060.0890.1060.1010.0980.093
Total Other Income Expenses Net 1,044.9-1,512-564.5-1,435.1-1,472.2-1,375.8-11.6-18.1-45.5-63.9-30.5-10.713.416.1-76.1613.7-41.4-55.5-24.8-51.3-47.2-43.7-60.8-54.2-94.5-50.8-50.6-59.1-45.7-732.4
Income Before Tax 1,044.9989.4939.6878.4975961.71,1291,306.91,066.61,2271,243.6575.8541.1932.6930.21,032.21,061.9698.9815.8632.3675.4764.9780634.5686.7667.3524.8581.8558.5522.5574
Income Before Tax Ratio 0.0980.1020.1010.0930.0990.1020.1160.1210.0870.1060.1220.0620.0620.1130.1250.1530.1480.1150.1310.1010.1040.1150.120.0930.10.0930.0820.0970.0920.090.095
Income Tax Expense 197.8192.2164.6164.7200.8209.9223.7244.8227.9223.3259.6119.6121.7164.4143.4179.9244.5134187.8152.44.7239.4209216223.5210.2124.5168.6150.3164141.3
Net Income 847.1797.2775713.7774.2751.8905.31,062.1838.71,003.7984456.2419.4768.2786.8852.3817.4564.9628479.9670.7525.5571418.5463.2457.1400.3413.2408.2358.5432.7
Net Income Ratio 0.080.0820.0830.0760.0790.080.0930.0980.0680.0870.0960.0490.0480.0930.1060.1260.1140.0930.1010.0770.1030.0790.0880.0620.0680.0640.0620.0690.0670.0620.072
EPS 23.922.4821.8620.1321.8421.225.5329.9623.6628.3127.7612.8611.8321.6722.1924.0423.0615.9317.7213.5418.9214.8216.1111.813.0712.8911.2911.6611.5110.1112.2
EPS Diluted 23.922.4821.8620.1321.8421.225.5329.9623.6528.3127.7612.8611.8321.6722.1924.0423.0615.9317.7213.5418.9214.8216.1111.813.0712.8911.2911.6611.5110.1112.2
EBITDA 1,363.41,240.81,016.61,188.71,275.71,256.6981,415.41,5781,327.71,460.21,461.5781.5759.11,130.11,199.61,225.11,260.9911.31,026.3855893.3973.2987.6834.6887.9870.4714780766.2718.3675.65
EBITDA Ratio 0.1280.1270.1090.1260.130.1330.1450.1460.1080.1260.1410.0840.0870.1370.1490.1820.1750.150.1660.1370.1380.1460.1530.1230.130.1220.1110.130.1260.1230.112